Karo Bio AB Announces Rights Issue of MSEK 38.7 and Calls an Extraordinary General Meeting
The Board of Directors of Karo Bio has decided to convene an Extraordinary
General Meeting on November 19, 2012 and there present a proposal to implement a
rights issue of approximately MSEK 38.7 with preferential rights for existing
shareholders. The purpose of the issue is to secure funding that will allow the
company to achieve a neutral cash flow, which is expected to be within reach in
2013.